This educational activity is intended for pulmonary specialists and other members of the health care team who care for patients with obstructive lung diseases such as COPD and asthma. Asthma and COPD ...

Chronic obstructive pulmonary disease (COPD) remains a substantial contributor to morbidity and mortality in the United States with an estimated 3.8% age-adjusted prevalence and 141,733 COPD deaths ...

CSA Medical, Inc., a medical device company focused on interventional pulmonary therapies, today announced the submission of ...

A Midtown-based medical device startup is carving a niche in the growing field of treatments to address chronic lung disease. Aerwave Medical raised $12 million in a recently closed deal to advance a ...

The approval is based on two placebo-controlled phase 3 studies, which showed mepolizumab significantly reduced the annualised rate of moderate/severe exacerbations and time to first moderate/severe ...

We currently know that COPD, and specifically emphysema, is not just a lung disease found alongside lung cancer; it increases ...

When one thinks of who is most likely to develop chronic obstructive pulmonary disease (COPD), a group of progressive, chronic lung diseases caused by inflammation and damage to the lungs, one ...

Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory diseases that cause breathing difficulty and coughing. Both conditions share similar symptoms. Understanding their ...

Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disorder characterised by persistent airflow limitation and chronic inflammation. Beyond its primary pulmonary manifestations, ...

Biomedical startups are taking aim at a deadly lung condition that has long lacked innovative treatments. Chronic obstructive pulmonary disease, caused by smoking and air pollution, hinders breathing ...